News & Articles
Selected Filters:
3D Cell Culture: Patient mini-brains, cancer insights, drug screening and more
Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications
Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Charles River acquires Retrogenix
Fundamentals of advanced spectral cell analysis using the ID7000™ system
Watch this on-demand webinar for expert insight into spectral cell analysis and how it may be used to generate parametric data
Twist Bioscience and Biotia receive FDA EUA for hybridization-based NGS SARS-CoV-2 assay
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
‘SelectScience offers a portal to learn about the newest technologies of our field’
Linda Lee, senior research scientist at C4 Therapeutics, describes how lab equipment reviews help to accelerate scientific progress
Nanolive launches EVE Analytics for the CX-A: A complete solution for live-cell imaging and analysis
Discover the automated, quantitative, and label-free software-hardware integration set to accelerate therapeutics research
World-class speaker lineup announced for Virtual Cancer and Immunology Research Summit 2021
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Thermo Fisher Scientific launches panel to monitor for COVID-19 mutations
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
Antimicrobial stewardship: Helping combat the spread of antimicrobial resistance
How blood culture diagnostics are enabling accurate pathogen identification, resistance detection, and timely therapy
Interleukin-6 test now helping to identify severe inflammatory response in COVID-19 patients
IL-6 assay aids in care management by determining patients at risk for intubation with mechanical ventilation
Avacta’s rapid antigen test is confirmed to detect SARS-CoV-2 new variants
Avacta’s AffiDX SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus
Abbott receives FDA EUA for test that detects SARS-CoV-2 and three other respiratory infections
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Consistency and quality in raw materials: Building blocks of a reliable in vitro diagnostic assay
Industry experts share insights on the elegant technology behind immunoassays and the critical raw materials that make them powerful
CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
Funding will advance 3D lung cell culture models to accelerate drug discovery
PerkinElmer has launched the first cell painting kit
New PhenoVue™ cell painting reagent kit makes the process of “painting” cells easier for research scientists by providing carefully selected and pre-optimized reagents
Sample preparation and enrichment for single-cell sequencing assays
Watch this on-demand webinar to understand sample requirements and basic optimization steps for single-cell assays
George Mason University employs rapid-result COVID-19 tests to control the spread of virus on campus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
PerkinElmer launches Solus One E. coli O157 Pathogen Detection Assay for beef & beef trim testing
This highly sensitive, cost effective assay is designed for customers who receive a high volume of food samples daily
Aalto Bio launches breakthrough diagnostic material for Rubella
New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives